The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Unit Dose Package Market Research Report 2024
Synopsis
Blister packaging, commonly known as unit dose packaging, is used in the pharmaceutical industry for packaging medicine. In blister packaging, a plastic sheet is thermoformed to form multiple cups or blisters that hold the product.
Global Pharmaceutical Unit Dose Package market is projected to reach US$ 45780 million in 2029, increasing from US$ 28670 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Unit Dose Package market research.
The pharma primary packaging market is driven by the growing pharmaceutical industry and the increasing focus on drug safety and quality. Pharma primary packaging refers to the materials used to directly contain and protect pharmaceutical products, ensuring their integrity and efficacy throughout their shelf life. The rise in drug development and the need for reliable and compliant packaging solutions contribute to market growth as pharma companies seek packaging that maintains product stability and prevents contamination. Moreover, advancements in packaging technology, such as blister packs and tamper-evident seals, have improved patient safety and medication adherence. However, the market also faces challenges, including the need for sustainable and eco-friendly packaging solutions to address environmental concerns. Additionally, addressing the complexity of regulatory requirements and ensuring compatibility with various drug formulations can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and compliant pharma primary packaging, collaborate with pharmaceutical companies to meet specific packaging needs, and address the challenges to meet the increasing demand for safe and reliable packaging solutions in the pharmaceutical industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Unit Dose Package market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amcor
Constantia Flexibles
Klöckner Pentaplast
Bemis
MeadWestvaco
Tekni-plex
Honeywell
CPH GROUP
Shanghai Haishun
Bilcare
IPS Ariflex
Zhong jin
Carcano Antonio
Aluberg
Goldstonepack
Segment by Type
PVC
Lidding Foils
Cold Form
PVDC
Other
Segment by Application
Capsule Drug
Tablets Drug
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pharmaceutical Unit Dose Package report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Blister packaging, commonly known as unit dose packaging, is used in the pharmaceutical industry for packaging medicine. In blister packaging, a plastic sheet is thermoformed to form multiple cups or blisters that hold the product.
Global Pharmaceutical Unit Dose Package market is projected to reach US$ 45780 million in 2029, increasing from US$ 28670 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Unit Dose Package market research.
The pharma primary packaging market is driven by the growing pharmaceutical industry and the increasing focus on drug safety and quality. Pharma primary packaging refers to the materials used to directly contain and protect pharmaceutical products, ensuring their integrity and efficacy throughout their shelf life. The rise in drug development and the need for reliable and compliant packaging solutions contribute to market growth as pharma companies seek packaging that maintains product stability and prevents contamination. Moreover, advancements in packaging technology, such as blister packs and tamper-evident seals, have improved patient safety and medication adherence. However, the market also faces challenges, including the need for sustainable and eco-friendly packaging solutions to address environmental concerns. Additionally, addressing the complexity of regulatory requirements and ensuring compatibility with various drug formulations can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and compliant pharma primary packaging, collaborate with pharmaceutical companies to meet specific packaging needs, and address the challenges to meet the increasing demand for safe and reliable packaging solutions in the pharmaceutical industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Unit Dose Package market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amcor
Constantia Flexibles
Klöckner Pentaplast
Bemis
MeadWestvaco
Tekni-plex
Honeywell
CPH GROUP
Shanghai Haishun
Bilcare
IPS Ariflex
Zhong jin
Carcano Antonio
Aluberg
Goldstonepack
Segment by Type
PVC
Lidding Foils
Cold Form
PVDC
Other
Segment by Application
Capsule Drug
Tablets Drug
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pharmaceutical Unit Dose Package report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Pharmaceutical Unit Dose Package Market Overview
1.1 Product Overview and Scope of Pharmaceutical Unit Dose Package
1.2 Pharmaceutical Unit Dose Package Segment by Type
1.2.1 Global Pharmaceutical Unit Dose Package Market Value Comparison by Type (2023-2029)
1.2.2 PVC
1.2.3 Lidding Foils
1.2.4 Cold Form
1.2.5 PVDC
1.2.6 Other
1.3 Pharmaceutical Unit Dose Package Segment by Application
1.3.1 Global Pharmaceutical Unit Dose Package Market Value by Application: (2023-2029)
1.3.2 Capsule Drug
1.3.3 Tablets Drug
1.3.4 Others
1.4 Global Pharmaceutical Unit Dose Package Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Unit Dose Package Revenue 2018-2029
1.4.2 Global Pharmaceutical Unit Dose Package Sales 2018-2029
1.4.3 Global Pharmaceutical Unit Dose Package Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pharmaceutical Unit Dose Package Market Competition by Manufacturers
2.1 Global Pharmaceutical Unit Dose Package Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Unit Dose Package Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pharmaceutical Unit Dose Package Average Price by Manufacturers (2018-2023)
2.4 Global Pharmaceutical Unit Dose Package Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharmaceutical Unit Dose Package, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Unit Dose Package, Product Type & Application
2.7 Pharmaceutical Unit Dose Package Market Competitive Situation and Trends
2.7.1 Pharmaceutical Unit Dose Package Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Unit Dose Package Players Market Share by Revenue
2.7.3 Global Pharmaceutical Unit Dose Package Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Unit Dose Package Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Unit Dose Package Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pharmaceutical Unit Dose Package Global Pharmaceutical Unit Dose Package Sales by Region: 2018-2029
3.2.1 Global Pharmaceutical Unit Dose Package Sales by Region: 2018-2023
3.2.2 Global Pharmaceutical Unit Dose Package Sales by Region: 2024-2029
3.3 Global Pharmaceutical Unit Dose Package Global Pharmaceutical Unit Dose Package Revenue by Region: 2018-2029
3.3.1 Global Pharmaceutical Unit Dose Package Revenue by Region: 2018-2023
3.3.2 Global Pharmaceutical Unit Dose Package Revenue by Region: 2024-2029
3.4 North America Pharmaceutical Unit Dose Package Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Unit Dose Package Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pharmaceutical Unit Dose Package Sales by Country (2018-2029)
3.4.3 North America Pharmaceutical Unit Dose Package Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Unit Dose Package Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Unit Dose Package Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pharmaceutical Unit Dose Package Sales by Country (2018-2029)
3.5.3 Europe Pharmaceutical Unit Dose Package Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Unit Dose Package Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Unit Dose Package Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pharmaceutical Unit Dose Package Sales by Country (2018-2029)
3.6.3 Asia Pacific Pharmaceutical Unit Dose Package Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Unit Dose Package Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Unit Dose Package Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pharmaceutical Unit Dose Package Sales by Country (2018-2029)
3.7.3 Latin America Pharmaceutical Unit Dose Package Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Unit Dose Package Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Unit Dose Package Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pharmaceutical Unit Dose Package Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pharmaceutical Unit Dose Package Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Unit Dose Package Sales by Type (2018-2029)
4.1.1 Global Pharmaceutical Unit Dose Package Sales by Type (2018-2023)
4.1.2 Global Pharmaceutical Unit Dose Package Sales by Type (2024-2029)
4.1.3 Global Pharmaceutical Unit Dose Package Sales Market Share by Type (2018-2029)
4.2 Global Pharmaceutical Unit Dose Package Revenue by Type (2018-2029)
4.2.1 Global Pharmaceutical Unit Dose Package Revenue by Type (2018-2023)
4.2.2 Global Pharmaceutical Unit Dose Package Revenue by Type (2024-2029)
4.2.3 Global Pharmaceutical Unit Dose Package Revenue Market Share by Type (2018-2029)
4.3 Global Pharmaceutical Unit Dose Package Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pharmaceutical Unit Dose Package Sales by Application (2018-2029)
5.1.1 Global Pharmaceutical Unit Dose Package Sales by Application (2018-2023)
5.1.2 Global Pharmaceutical Unit Dose Package Sales by Application (2024-2029)
5.1.3 Global Pharmaceutical Unit Dose Package Sales Market Share by Application (2018-2029)
5.2 Global Pharmaceutical Unit Dose Package Revenue by Application (2018-2029)
5.2.1 Global Pharmaceutical Unit Dose Package Revenue by Application (2018-2023)
5.2.2 Global Pharmaceutical Unit Dose Package Revenue by Application (2024-2029)
5.2.3 Global Pharmaceutical Unit Dose Package Revenue Market Share by Application (2018-2029)
5.3 Global Pharmaceutical Unit Dose Package Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amcor
6.1.1 Amcor Corporation Information
6.1.2 Amcor Description and Business Overview
6.1.3 Amcor Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amcor Pharmaceutical Unit Dose Package Product Portfolio
6.1.5 Amcor Recent Developments/Updates
6.2 Constantia Flexibles
6.2.1 Constantia Flexibles Corporation Information
6.2.2 Constantia Flexibles Description and Business Overview
6.2.3 Constantia Flexibles Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Constantia Flexibles Pharmaceutical Unit Dose Package Product Portfolio
6.2.5 Constantia Flexibles Recent Developments/Updates
6.3 Klöckner Pentaplast
6.3.1 Klöckner Pentaplast Corporation Information
6.3.2 Klöckner Pentaplast Description and Business Overview
6.3.3 Klöckner Pentaplast Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Klöckner Pentaplast Pharmaceutical Unit Dose Package Product Portfolio
6.3.5 Klöckner Pentaplast Recent Developments/Updates
6.4 Bemis
6.4.1 Bemis Corporation Information
6.4.2 Bemis Description and Business Overview
6.4.3 Bemis Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bemis Pharmaceutical Unit Dose Package Product Portfolio
6.4.5 Bemis Recent Developments/Updates
6.5 MeadWestvaco
6.5.1 MeadWestvaco Corporation Information
6.5.2 MeadWestvaco Description and Business Overview
6.5.3 MeadWestvaco Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.5.4 MeadWestvaco Pharmaceutical Unit Dose Package Product Portfolio
6.5.5 MeadWestvaco Recent Developments/Updates
6.6 Tekni-plex
6.6.1 Tekni-plex Corporation Information
6.6.2 Tekni-plex Description and Business Overview
6.6.3 Tekni-plex Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tekni-plex Pharmaceutical Unit Dose Package Product Portfolio
6.6.5 Tekni-plex Recent Developments/Updates
6.7 Honeywell
6.6.1 Honeywell Corporation Information
6.6.2 Honeywell Description and Business Overview
6.6.3 Honeywell Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Honeywell Pharmaceutical Unit Dose Package Product Portfolio
6.7.5 Honeywell Recent Developments/Updates
6.8 CPH GROUP
6.8.1 CPH GROUP Corporation Information
6.8.2 CPH GROUP Description and Business Overview
6.8.3 CPH GROUP Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CPH GROUP Pharmaceutical Unit Dose Package Product Portfolio
6.8.5 CPH GROUP Recent Developments/Updates
6.9 Shanghai Haishun
6.9.1 Shanghai Haishun Corporation Information
6.9.2 Shanghai Haishun Description and Business Overview
6.9.3 Shanghai Haishun Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shanghai Haishun Pharmaceutical Unit Dose Package Product Portfolio
6.9.5 Shanghai Haishun Recent Developments/Updates
6.10 Bilcare
6.10.1 Bilcare Corporation Information
6.10.2 Bilcare Description and Business Overview
6.10.3 Bilcare Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bilcare Pharmaceutical Unit Dose Package Product Portfolio
6.10.5 Bilcare Recent Developments/Updates
6.11 IPS Ariflex
6.11.1 IPS Ariflex Corporation Information
6.11.2 IPS Ariflex Pharmaceutical Unit Dose Package Description and Business Overview
6.11.3 IPS Ariflex Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.11.4 IPS Ariflex Pharmaceutical Unit Dose Package Product Portfolio
6.11.5 IPS Ariflex Recent Developments/Updates
6.12 Zhong jin
6.12.1 Zhong jin Corporation Information
6.12.2 Zhong jin Pharmaceutical Unit Dose Package Description and Business Overview
6.12.3 Zhong jin Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zhong jin Pharmaceutical Unit Dose Package Product Portfolio
6.12.5 Zhong jin Recent Developments/Updates
6.13 Carcano Antonio
6.13.1 Carcano Antonio Corporation Information
6.13.2 Carcano Antonio Pharmaceutical Unit Dose Package Description and Business Overview
6.13.3 Carcano Antonio Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Carcano Antonio Pharmaceutical Unit Dose Package Product Portfolio
6.13.5 Carcano Antonio Recent Developments/Updates
6.14 Aluberg
6.14.1 Aluberg Corporation Information
6.14.2 Aluberg Pharmaceutical Unit Dose Package Description and Business Overview
6.14.3 Aluberg Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Aluberg Pharmaceutical Unit Dose Package Product Portfolio
6.14.5 Aluberg Recent Developments/Updates
6.15 Goldstonepack
6.15.1 Goldstonepack Corporation Information
6.15.2 Goldstonepack Pharmaceutical Unit Dose Package Description and Business Overview
6.15.3 Goldstonepack Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Goldstonepack Pharmaceutical Unit Dose Package Product Portfolio
6.15.5 Goldstonepack Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Unit Dose Package Industry Chain Analysis
7.2 Pharmaceutical Unit Dose Package Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Unit Dose Package Production Mode & Process
7.4 Pharmaceutical Unit Dose Package Sales and Marketing
7.4.1 Pharmaceutical Unit Dose Package Sales Channels
7.4.2 Pharmaceutical Unit Dose Package Distributors
7.5 Pharmaceutical Unit Dose Package Customers
8 Pharmaceutical Unit Dose Package Market Dynamics
8.1 Pharmaceutical Unit Dose Package Industry Trends
8.2 Pharmaceutical Unit Dose Package Market Drivers
8.3 Pharmaceutical Unit Dose Package Market Challenges
8.4 Pharmaceutical Unit Dose Package Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
